Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit

Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis

NCT05681442 ·Status: RECRUITING ·Phase: PHASE4

Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit

NCT01085994 ·Status: UNKNOWN

Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients

NCT05024565 ·Status: UNKNOWN ·Phase: NA

Descriptive Study of the Evolution in Proportion of Regulatory B Lymphocytes in Patients Hospitalized in Intensive Care for Severe Sepsis

NCT03115125 ·Status: UNKNOWN ·Phase: NA

Epidemiology of Septic Shock in Medical or Polyvalent ICU in the North-East Region of France

NCT01903746 ·Status: TERMINATED

Septic Shock-induced Immunosuppression

NCT04067674 ·Status: RECRUITING

Mortality of Sepsis in Swedish Intensive Care Units 2008-2016

NCT03489447 ·Status: COMPLETED

Risk Factors for Beta-lactam Target Non Attainment in Critically Ill Patients BETALACTACRIT

NCT06596096 ·Status: COMPLETED

Impact of a Procalcitonin Testing and Treatment Algorithm on Antibiotic Use and Outcomes in the Pediatric Intensive Care Unit

NCT03440918 ·Status: COMPLETED ·Phase: NA

Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.

NCT07200817 ·Status: RECRUITING

Therapeutic Monitoring of Antibiotics in Intensive Care Patients: a Cohort Study PopTDM-ICU

NCT05367011 ·Status: NOT_YET_RECRUITING

Epidemiology of Neonatal Sepsis in Neonatal Intensive Care Unit in Assiut University Children Hospital

NCT03354650 ·Status: UNKNOWN

Derivation and Validation of a Prognostic Model for Septic Patients at Hospital Admission

NCT03601767 ·Status: UNKNOWN

Short-course Antimicrobial Therapy in Sepsis

NCT02899143 ·Status: UNKNOWN ·Phase: PHASE2

Treatment Outcome With Antibiotic Use and Its Resistance Pattern Among Patient With Neonatal Sepsis

NCT05742477 ·Status: UNKNOWN

Procalcitonin to Shorten Antibiotics Duration in ICU Patients

NCT01379547 ·Status: UNKNOWN ·Phase: PHASE3

Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)

NCT02803346 ·Status: UNKNOWN

Retrospective Examination of Initial Care of Severe Bacterial Infections of the Child

NCT01485705 ·Status: COMPLETED ·Phase: NA

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children

NCT03441126 ·Status: COMPLETED

Prognostic Value of Complete Blood Count in Severe Infections

NCT03685071 ·Status: UNKNOWN

Prospective Validation of Clini-biological Parameters Including Initial Hemostasis, Which Improve the Prediction of Death at 1 Month Among Patients With Septic Shock

NCT01231672 ·Status: COMPLETED

Mortality Due to Septic Shock Associated With Thrombocytopenia

NCT03617965 ·Status: UNKNOWN

Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis

NCT02898961 ·Status: COMPLETED ·Phase: PHASE4

Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients

NCT03344627 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Procalcitonin Guided Antibiotic Therapy in Adult Intensive Care Units (ICU's)

NCT01139489 ·Status: COMPLETED ·Phase: NA